Figure 3 | Modern Pathology

Figure 3

From: Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome

Figure 3

Kaplan–Meier curves illustrating biochemical recurrence-free survival among prostate cancer patients defined by the status of selected clinicopathological parameters, TMPRSS2:ERG rearrangements and PTEN copy number changes; (+) presence, (−) absence. (a) PSA recurrence-free survival curve stratified by the TMPRSS2:ERG rearrangements (absence or presence of gene fusion) on 122 prostate cancer patients and (b) when duplicate TMPRSS2:ERG FISH fusion signals were present (red curve) the outcome was the least favorable. (c) PSA recurrence-free survival analysis stratified by TMPRSS2:ERG rearrangements and PTEN copy number changes on 82 prostate cancer patients.

Back to article page